CClinicalTrials.gg
CompletedNCT04275089Updated Jul 28, 2023Results posted

Early Feasibility Study of the Reia Vaginal Pessary

An interventional study of Reia Vaginal Pessary in Pelvic Organ Prolapse and Prolapse, sponsored by Reia, LLC. Completed at 1 site in United States. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-07-28.

Sponsored by Reia, LLC · Not applicable, Interventional, and Device feasibility

Phase
Not applicable
Study type
Interventional
Enrollment
15
Allocation
Not applicable
Ages
18 Years and older
Sex
Female
01

Study summary

This is an early feasibility open-label non-randomized trial to obtain preliminary information about the function and effectiveness of a novel vaginal pessary for the use in women who suffer from symptoms of pelvic organ prolapse (POP). Recruited patients will have Stage II POP or greater and will be current users of a legally marketed vaginal pessary. In a single visit, data will be collected on the performance and comfort of the subject's current pessary. After placement of a study pessary, comparative data will be collected between subject's current pessary and the study pessary on ability to support prolapse. The study pessary's function will be assessed under controlled circumstances. The patient will have her current pessary replaced at the conclusion of the visit. Results will be used to inform future design modifications of the study pessary.

02

Conditions studied

  • Pelvic Organ Prolapse
  • Prolapse
03

In context

Prolapse

676 studies on the registry are indexed under Prolapse; 79 are open to participants now.

This study's enrollment of 15 is below the median of 74 across 435 interventional studies indexed under Prolapse.

Browse Prolapse studies →

Lead sponsor

Reia, LLC is the lead sponsor of 2 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Women with Stage II pelvic organ prolapse or greater
  • Current ring style or Gellhorn pessary users inclusive of sizes 1.5"-3.5"
  • Capable of giving informed consent

Exclusion criteria

Exclusion Criteria:

  • Pregnancy
  • Deep vaginal erosion noted with removal of current pessary
  • Presence of vesicovaginal fistula
  • Presence of rectovaginal fistula
  • Vaginal, rectal, or bladder tumor
  • Inflammatory Bowel Disease
  • Presence of open wound or tear near vagina or anus by exam prior to removal of current pessary
  • Current vaginal or urinary infection requiring treatment
  • Previous pelvic floor surgery in last 12 months
  • Congenital malformation of bladder, rectum, or vagina
  • Significant medical condition interfering with study participation (psychologic, neurologic, active drug/alcohol abuse, etc.)
  • Planning pregnancy in next 6 months
05

Study design

Phase
Not applicable
Primary purpose
Device feasibility
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
15 participants (actual)

Study arms

  • Experimental
    Reia Vaginal Pessary

    Device: Reia Vaginal Pessary

Interventions

  • DeviceReia Vaginal Pessary

    Reia Vaginal Pessary

06

What researchers measure

Primary outcomes

  1. The Ability of the Study Device to be Retained During Valsalva Compared to the Ability of the Subject's Current Pessary to be Retained During Valsalva (Change in Distance Between Current Pessary and Study Pessary to Leading Edge to the Hymen)

    The subject will be asked to Valsalva with their current pessary in place, and the distance from the leading edge of the current pessary to the hymen will be measured in centimeters. After the current pessary is removed and with the study pessary in place, the subject will be asked to Valsalva again. The distance from the leading edge of the study pessary to the hymen will be measured in centimeters. In order to assess the ability of the study pessary to function and be retained, the measurements will be compared.

    Time frame: During treatment - within 1 hour

  2. The Ability of the Study Device to be Retained Throughout Regular Activity (by Vaginal Examination)

    With the study pessary in place, the subject will be asked to ambulate for 10 minutes and attempt to void. Following these activities, whether the pessary was retained or expelled will be recorded.

    Time frame: During treatment - within 1 hour

Secondary outcomes

  1. Shape of the Study Pessary During Expulsion if it is Not Able to be Retained (by Vaginal Examination)

    The subject will be asked to Valsalva. If the study device is expelled during Valsalva, whether the study device was expelled fully deployed or whether it prematurely folded to its collapsed state will be recorded.

    Time frame: During treatment - within 1 hour

  2. Orientation of the Study Pessary Stem Following Regular Activity (by Vaginal Examination)

    Following ambulation and attempting to void and prior to removing the study pessary, it will be recorded if the study device's stem rotated out of its original inserted position.

    Time frame: During treatment - within 1 hour

  3. Discomfort Experienced With Removal of the Study Pessary Subtracted From the Discomfort Experienced With Removal of the Subject's Current Pessary (Change in VAS) [Positive Score Indicates Lower Discomfort With Study Pessary]

    To indicate discomfort, the subject will be shown and asked to mark a visual analogue scale (VAS) after removal of her current pessary and before using the study pessary. The VAS will be a 10 centimeter linear continuum in which 0 represents no pain and 10 represents worst pain. After use of the study pessary and upon removal of the study pessary, the subject will be shown and asked to mark another VAS. In order to assess the discomfort experienced during removal of the study pessary, the distance from 0 to the subject's mark will be measured and compared between the two scales. The outcome measure is \[VAS after removal of current pessary\] - \[VAS after removal of study pessary\].

    Time frame: During treatment - within 1 hour

  4. Discomfort Experienced With Insertion of the Study Pessary Subtracted From the Discomfort Experienced With Insertion of the Subject's Current Pessary (Change in VAS) [Positive Score Indicates Lower Discomfort With Study Pessary]

    To indicate discomfort, the subject will be shown and asked to mark a VAS after insertion of the study pessary. The VAS will be a 10 centimeter linear continuum in which 0 represents no pain and 10 represents worst pain. After use of the study pessary and upon insertion of the subject's current pessary, the subject will also be shown and asked to mark another VAS. In order to assess the discomfort experienced during insertion of the study pessary, the distance from 0 to the subject's mark will be measured and compared between the two scales. The outcome measure is \[VAS after insertion of current pessary\] - \[VAS after insertion of study pessary\].

    Time frame: During treatment - within 1 hour

  5. Global Comfort Associated With Use of the Study Pessary (by Verbal Description)

    Following insertion of the subject's current pessary, and after the subject is dressed, she will be asked whether the study pessary was more, less, or as comfortable as her current pessary when it was in situ. If she responds it was more or less comfortable, she will be asked to describe why.

    Time frame: Post treatment - within or at 1 hour

07

Results

Posted Jul 28, 2023

Participant flow

Participant flow — Overall Study
MilestoneReia Vaginal Pessary
Started15
Completed14
Not completed1
Withdrew: Unable to be fit with reia pessary1

Outcome measures

PrimaryThe Ability of the Study Device to be Retained During Valsalva Compared to the Ability of the Subject's Current Pessary to be Retained During Valsalva (Change in Distance Between Current Pessary and Study Pessary to Leading Edge to the Hymen)

The subject will be asked to Valsalva with their current pessary in place, and the distance from the leading edge of the current pessary to the hymen will be measured in centimeters. After the current pessary is removed and with the study pessary in place, the subject will be asked to Valsalva again. The distance from the leading edge of the study pessary to the hymen will be measured in centimeters. In order to assess the ability of the study pessary to function and be retained, the measurements will be compared.

Time frame:
During treatment - within 1 hour
Reported as:
Median · cm
The Ability of the Study Device to be Retained During Valsalva Compared to the Ability of the Subject's Current Pessary to be Retained During Valsalva (Change in Distance Between Current Pessary and Study Pessary to Leading Edge to the Hymen)
cmReia Vaginal Pessary
The Ability of the Study Device to be Retained During Valsalva Compared to the Ability of the Subject's Current Pessary to be Retained During Valsalva (Change in Distance Between Current Pessary and Study Pessary to Leading Edge to the Hymen)0 ± 1.7
PrimaryThe Ability of the Study Device to be Retained Throughout Regular Activity (by Vaginal Examination)

With the study pessary in place, the subject will be asked to ambulate for 10 minutes and attempt to void. Following these activities, whether the pessary was retained or expelled will be recorded.

Time frame:
During treatment - within 1 hour
Reported as:
Number · participants
The Ability of the Study Device to be Retained Throughout Regular Activity (by Vaginal Examination)
participantsReia Vaginal Pessary
pessary retained14
pessary expelled0
SecondaryShape of the Study Pessary During Expulsion if it is Not Able to be Retained (by Vaginal Examination)

The subject will be asked to Valsalva. If the study device is expelled during Valsalva, whether the study device was expelled fully deployed or whether it prematurely folded to its collapsed state will be recorded.

Time frame:
During treatment - within 1 hour
Reported as:
Count of participants · Participants
Shape of the Study Pessary During Expulsion if it is Not Able to be Retained (by Vaginal Examination)
ParticipantsReia Vaginal Pessary
Not expelled14
Expelled in collapsed state0
Expelled in deployed state0
SecondaryOrientation of the Study Pessary Stem Following Regular Activity (by Vaginal Examination)

Following ambulation and attempting to void and prior to removing the study pessary, it will be recorded if the study device's stem rotated out of its original inserted position.

Time frame:
During treatment - within 1 hour
Reported as:
Number · participants
Orientation of the Study Pessary Stem Following Regular Activity (by Vaginal Examination)
participantsReia Vaginal Pessary
Rotated1
Not rotated13
SecondaryDiscomfort Experienced With Removal of the Study Pessary Subtracted From the Discomfort Experienced With Removal of the Subject's Current Pessary (Change in VAS) [Positive Score Indicates Lower Discomfort With Study Pessary]

To indicate discomfort, the subject will be shown and asked to mark a visual analogue scale (VAS) after removal of her current pessary and before using the study pessary. The VAS will be a 10 centimeter linear continuum in which 0 represents no pain and 10 represents worst pain. After use of the study pessary and upon removal of the study pessary, the subject will be shown and asked to mark another VAS. In order to assess the discomfort experienced during removal of the study pessary, the distance from 0 to the subject's mark will be measured and compared between the two scales. The outcome measure is \[VAS after removal of current pessary\] - \[VAS after removal of study pessary\].

Time frame:
During treatment - within 1 hour
Reported as:
Mean · cm
Discomfort Experienced With Removal of the Study Pessary Subtracted From the Discomfort Experienced With Removal of the Subject's Current Pessary (Change in VAS) [Positive Score Indicates Lower Discomfort With Study Pessary]
cmReia Vaginal Pessary
Discomfort Experienced With Removal of the Study Pessary Subtracted From the Discomfort Experienced With Removal of the Subject's Current Pessary (Change in VAS) [Positive Score Indicates Lower Discomfort With Study Pessary]1.4 (-1.3 to 4.3)
SecondaryDiscomfort Experienced With Insertion of the Study Pessary Subtracted From the Discomfort Experienced With Insertion of the Subject's Current Pessary (Change in VAS) [Positive Score Indicates Lower Discomfort With Study Pessary]

To indicate discomfort, the subject will be shown and asked to mark a VAS after insertion of the study pessary. The VAS will be a 10 centimeter linear continuum in which 0 represents no pain and 10 represents worst pain. After use of the study pessary and upon insertion of the subject's current pessary, the subject will also be shown and asked to mark another VAS. In order to assess the discomfort experienced during insertion of the study pessary, the distance from 0 to the subject's mark will be measured and compared between the two scales. The outcome measure is \[VAS after insertion of current pessary\] - \[VAS after insertion of study pessary\].

Time frame:
During treatment - within 1 hour
Reported as:
Mean · cm
Discomfort Experienced With Insertion of the Study Pessary Subtracted From the Discomfort Experienced With Insertion of the Subject's Current Pessary (Change in VAS) [Positive Score Indicates Lower Discomfort With Study Pessary]
cmReia Vaginal Pessary
Discomfort Experienced With Insertion of the Study Pessary Subtracted From the Discomfort Experienced With Insertion of the Subject's Current Pessary (Change in VAS) [Positive Score Indicates Lower Discomfort With Study Pessary]1.3 (-1.2 to 5.7)
SecondaryGlobal Comfort Associated With Use of the Study Pessary (by Verbal Description)

Following insertion of the subject's current pessary, and after the subject is dressed, she will be asked whether the study pessary was more, less, or as comfortable as her current pessary when it was in situ. If she responds it was more or less comfortable, she will be asked to describe why.

Time frame:
Post treatment - within or at 1 hour
Reported as:
Count of participants · Participants
Global Comfort Associated With Use of the Study Pessary (by Verbal Description)
ParticipantsReia Vaginal Pessary
Study pessary more comfortable2
Equal comfort6
Current pessary more comfortable5

Adverse events

Collected over Duration of subject's sole study visit - within one hour. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Reia Vaginal Pessary0/15 (0%)0/15 (0%)0/15 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)Reia Vaginal Pessary
Mean78 (63 to 93)
Sex: Female, Male
Sex: Female, Male(Participants)Reia Vaginal Pessary
Female15
Male0
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Reia Vaginal Pessary
Hispanic or Latino0
Not Hispanic or Latino14
Unknown or Not Reported1
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Reia Vaginal Pessary
American Indian or Alaska Native0
Asian0
Native Hawaiian or Other Pacific Islander0
Black or African American0
White14
More than one race0
Unknown or Not Reported1
Region of Enrollment
Region of Enrollment(participants)Reia Vaginal Pessary
United States15
Pessary type
Pessary type(Participants)Reia Vaginal Pessary
Gellhorn8
Ring7
BMI
BMI(Participants)Reia Vaginal Pessary
<201
20-309
>305
Menopause status
Menopause status(Participants)Reia Vaginal Pessary
Post menopause15
Pre menopause0

1 further baseline measures are reported on the registry.

08

Study locations

1 site
  • Dartmouth-Hitchcock Medical Center
    Lebanon, New Hampshire 03756, United States
09

References and documents

Study documents

  • Study protocol · Nov 5, 2020
  • Statistical analysis plan · Feb 17, 2020
  • Informed consent form · Dec 10, 2020

Documents are hosted by the registry — open the source record to download them.

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 28, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT04275089
Lead sponsor
Reia, LLC
Responsible party
Sponsor
First posted
Feb 19, 2020
Start date
Nov 5, 2020
Primary completion
Jan 20, 2021
Completion
Jan 20, 2021
Results posted
Jul 28, 2023
Last update
Jul 28, 2023

Study contacts

Kris Strohbehn, MD
principal investigator · Dartmouth-Hitchcock Clinic

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion